Close Window

Digital Look Email A Friend

Hutchmed completes trial enrolment, keeps drugs on China funding list

Published by Josh White on 13th December 2023

(Sharecast News) - Hutchmed China announced a significant milestone in its clinical trials on Wednesday, as well as the inclusion of two of its drugs on the National Reimbursement Drug List (NRDL) in China.

URL: http://www.digitallook.com/dl/news/story/33969702/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.